CCR5, CCR7, CXCR3, CXCR6 (Approved for MS. Mixture of random-sized peptides that mimic myelin basic protein, acting as a decoy. Reduced relapse rate by 29%. Modulates CCR1, CCR2, CCR3, CCR7, CCR9, CCR10, CXCR1, CXCR4, CXCR5, CXCR6, and CCR6.) This evidence concerns the gene CCR7 and myeloid sarcoma.